These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8156579)
21. Trace element status (Se, Cu, Zn) in healthy Portuguese subjects of Lisbon population: a reference study. Lopes PA; Santos MC; Vicente L; Rodrigues MO; Pavão ML; Nève J; Viegas-Crespo AM Biol Trace Elem Res; 2004 Oct; 101(1):1-17. PubMed ID: 15516699 [TBL] [Abstract][Full Text] [Related]
22. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T Thorac Cardiovasc Surg; 2005 Oct; 53(5):300-4. PubMed ID: 16208617 [TBL] [Abstract][Full Text] [Related]
23. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer]. Li R; Li R; Wang Y Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296 [TBL] [Abstract][Full Text] [Related]
24. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer. Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764 [TBL] [Abstract][Full Text] [Related]
25. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
26. Elastin metabolism parameters in sera of patients with lung cancer. Gmiński J; Mykala-Cieśla J; Machalski M; Drózdz M Neoplasma; 1993; 40(1):41-4. PubMed ID: 8394514 [TBL] [Abstract][Full Text] [Related]
27. Serum zinc, selenium and copper in priest subjects. Mahaisiriyodom A; Viroonudomphol D J Med Assoc Thai; 2008; 91 Suppl 1():S145-50. PubMed ID: 18672606 [TBL] [Abstract][Full Text] [Related]
28. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963 [TBL] [Abstract][Full Text] [Related]
29. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia. Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068 [TBL] [Abstract][Full Text] [Related]
30. Serum endostatin levels in patients with lung carcinoma. Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965 [TBL] [Abstract][Full Text] [Related]
31. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986 [TBL] [Abstract][Full Text] [Related]
32. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437 [TBL] [Abstract][Full Text] [Related]
34. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Lin CC; Huang JF; Tsai LY; Huang YL Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099 [TBL] [Abstract][Full Text] [Related]
35. Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer. Yildirim A; Meral M; Kaynar H; Polat H; Ucar EY Med Sci Monit; 2007 Apr; 13(4):CR195-200. PubMed ID: 17392651 [TBL] [Abstract][Full Text] [Related]
36. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)]. Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188 [TBL] [Abstract][Full Text] [Related]
37. Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients. Hataji O; Taguchi O; Gabazza EC; Yuda H; D'Alessandro-Gabazza CN; Fujimoto H; Nishii Y; Hayashi T; Suzuki K; Adachi Y Am J Hematol; 2004 Jul; 76(3):214-9. PubMed ID: 15224354 [TBL] [Abstract][Full Text] [Related]
38. Blood serum selenium in the province of Mérida, Venezuela, related to sex, cancer incidence and soil selenium content. Burguera JL; Burguera M; Gallignani M; Alarcón OM; Burguera JA J Trace Elem Electrolytes Health Dis; 1990 Jun; 4(2):73-7. PubMed ID: 2136228 [TBL] [Abstract][Full Text] [Related]
39. Plasma selenium level in cancer patients. Gupta S; Narang R; Krishnaswami K; Yadav S Indian J Cancer; 1994 Sep; 31(3):192-7. PubMed ID: 8557298 [TBL] [Abstract][Full Text] [Related]
40. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]